Proper management at earlier stage of anemia, for men with Hb 13–13.9 g/dL and individuals with mild anemia, might prevent CKD development in the general population and prevent progression to ESRD in CKD patients. The gene discussed is GSTM1; the disease is chronic kidney disease.